Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Press Iceland.
Higher Levels of Trust Determine 2025 Fortune 100 Best Companies to Work For Europe
Oakland, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Great Place To Work® announced the 2025 Fortune 100 Best Companies to Work For™ Europe, marking its second year of partnering with Fortune Europe. To select the list, Great Place To Work surveyed...
 
    
  BlueCat appoints Kevin Shone as Chief Financial Officer
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- BlueCat, a leading provider of Intelligent Network Operations Solutions that help organizations modernize, optimize, and secure their network infrastructure, today announced the appointment of Kevin...
 
    
  What if? “Strategic Competition” vs. “Selective Cooperation”
Back to Publications April 2025 Central Arctic Ocean Roundtable event at Tongji University. Photo: Min Pan A prominent Western narrative portrays China as eagerly pursuing economic and strategic goals in the Arctic. U.S. Defense Department...
 
    
  Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
ZUG, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical...
 
    
  The Global Myeloma Community Mourns the Passing of IMF Co-Founder Dr. Brian G.M. Durie
LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the organization. A Media Snippet accompanying this...
 
    
  Tilde enters the global AI race with a European multilingual model and safeguards against disinformation
Latvian AI company Tilde has unveiled TildeOpen LLM, an open-source large language model trained on Europe’s flagship supercomputer LUMI. RīGA, LATVIA, October 16, 2025 /EINPresswire.com/ -- With 30 billion parameters, TildeOpen outperforms...
 
    
  Diabetic Retinopathy Market to Reach USD 17.82 Billion by 2034 as Diabetes Cases and Aging Population Rise
Ottawa, Sept. 17, 2025 (GLOBE NEWSWIRE) -- According to a study released by Towards Healthcare, a sister firm of Precedence Research, the diabetic retinopathy market was valued at USD 9.52 billion in 2024 and is anticipated to witness steady...
 
    
  Bellame Expands Global Shipping to 17 Countries and Introduces 7-Day-a-Week Fulfillment to Meet Rising Demand
Bellame Expands Global Shipping to 17 Countries and Introduces 7-Day-a-Week Fulfillment to Meet Rising Demand FORT WORTH, TX, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Bellame, the luxury beauty and wellness brand redefining modern...
 
    
  Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics
Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Axelyf, Inc., a biotechnology...
 
    
  Industry Leaders Share Strategic Outlooks Ahead of the Scandinavian and Nordic Gaming Show 2025
STOCKHOLM, SWEDEN, September 30, 2025 /EINPresswire.com/ -- In three weeks, the highly anticipated 7th Annual Scandinavian & Nordic Gaming Show 2025 will assemble the region’s most influential regulators, operators, and technology leaders in...
 
    
  Tourism Source Market to Surge USD 1.1 Trillion by 2032, Size, Share, Emerging Trends, Key Growth Drivers
Based on booking channels, the mobile application segment had the major Tourism Source Market Share and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, October 15, 2025 /EINPresswire.com/ -- The Tourism...
Assembly Calls for Stronger Democratic Resilience in face of Foreign Interference
12 October 2025 LJUBLJANA – Allied nations must bolster the democratic resilience of their societies in the face of interference from hostile foreign powers, the NATO Parliamentary Assembly warned Sunday. “Foreign interference aims to threaten the...
 
    
  FIDELITY to Premiere at Chelsea Film Festival: A Daughter’s Search for Connection in the Age of Artificial Intimacy
New York, Oct. 13, 2025 (GLOBE NEWSWIRE) -- A young actress steps into the role of a dying man's estranged daughter, and finds herself confronting the unresolved loss of her own father. FIDELITY, the debut feature from writer-director Roberto...
 
    
  Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical...
 
    
  Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinical...
 
    
  Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 eye drops in diabetic macular edema (DME) to be...
 
    
  Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...
 
    
  
 
    
  Oculis to Participate in Upcoming September Investor Conferences
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
 
    
  EU to launch new Entry/Exit System for non-EU travellers on 12 October 2025
The EES is an advanced technological system that will digitally record the entry and exit information of non-EU nationals travelling to 29 countries in the Schengen area: 25 EU member states, as well as Norway, Liechtenstein, Iceland and...